Insiders · UNCY

John Townsend

CFO at Unicycive Therapeutics, Inc. (UNCY)

John Townsend has filed 7 insider reports with the SEC since November 2022, as CFO at Unicycive Therapeutics, Inc. (UNCY). The latest filing, on June 15, 2026, reports grant or award at Unicycive Therapeutics, Inc. (UNCY).

Filings
7
Companies
1
Bought on market
None
Sold on market
None

Companies where John Townsend is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Unicycive Therapeutics, Inc. logo
UNCY
Unicycive Therapeutics, Inc.
CFO$3.53Jun 15, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare John Townsend with

Other insiders at the same companies

Questions about John Townsend

What is John Townsend's role at Unicycive Therapeutics, Inc.?
John Townsend reports to the SEC as CFO at Unicycive Therapeutics, Inc. (UNCY), according to the latest filing on June 15, 2026.
Has John Townsend bought or sold stock recently?
No open-market purchases or sales by John Townsend are on file. The filings report grant or award.
How do I get alerts when John Townsend files?
Follow John Townsend on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by John Townsend (SEC CIK 0001511906). Totals count each trade once, skipping amendments whose original is on file, from Nov 23, 2022 on. View on SEC EDGAR · Get this as JSON